Covered recipient · General Payments record
EDWARD M SALIBA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$785.19
- Reported across 41 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $300.94 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $90.23 | 6 |
| Acerta Pharma LLC | $48.34 | 3 |
| Novo Nordisk AS | $45.39 | 3 |
| Corcept Therapeutics | $44.68 | 2 |
| OptiNose US, Inc. | $22.08 | 1 |
| GlaxoSmithKline, LLC. | $16.97 | 1 |
| PFIZER INC. | $16.82 | 1 |
| Antares Pharma, Inc. | $16.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Antares Pharma, Inc. | $16.43 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146521425 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.19 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105314467 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.60 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104610060 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.55 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104405831 | CMS |
| Corcept Therapeutics | $22.26 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117789757 | CMS |
| Corcept Therapeutics | $22.42 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117789837 | CMS |
| GlaxoSmithKline, LLC. | $16.97 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116060975 | CMS |
| Lilly USA, LLC | $14.50 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135631508 | CMS |
| Lilly USA, LLC | $14.33 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135631510 | CMS |
| Lilly USA, LLC | $16.34 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135614807 | CMS |
| Lilly USA, LLC | $16.32 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135614527 | CMS |
| Lilly USA, LLC | $15.17 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135575440 | CMS |
| Lilly USA, LLC | $13.57 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135575442 | CMS |
| Novo Nordisk Inc | $15.87 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100338143 | CMS |
| Novo Nordisk Inc | $15.22 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100479945 | CMS |
| Novo Nordisk Inc | $14.30 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100515613 | CMS |
| Optinose US, Inc. | $22.08 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142182962 | CMS |
| PFIZER INC. | $16.82 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131954089 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.